INDI:NASDAQindie Semiconductor, Inc. Analysis
Data as of 2026-06-14 - not real-time
$4.10
Latest Price
8/10Risk
Risk Level: High
Executive Summary
indie Semiconductor is trading close to a technical support zone while its 20‑day moving average sits above the 50‑day average, suggesting a short‑term bullish alignment. The RSI hovers around the midpoint, indicating little momentum pressure, but the MACD histogram remains negative, pointing to lingering bearish momentum. Beta is markedly above market averages, amplifying price swings that are already evident in a 30‑day volatility exceeding 100 percent. The stock’s price is also approaching its recent resistance level, leaving upside potential limited in the near term. Fundamentally, the company reports negative margins across the board, a substantial debt load relative to equity, and negative cash flow, which dampens the bullish technical picture. On the positive side, the firm operates in the fast‑growing automotive semiconductor and ADAS space, and analysts collectively rate it a buy with a median price target above current levels. Recent media headlines tout the stock as a cheap semiconductor play, while a major broker maintains a neutral stance, underscoring mixed sentiment. Balancing high technical volatility, a leveraged balance sheet, and sector growth prospects, the stock presents a nuanced risk‑reward profile that leans toward cautious optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with bearish MACD
- Extreme short‑term volatility and high beta
- Negative cash flow and heavy debt burden
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Industry tailwinds in autonomous‑vehicle semiconductors
- Analyst consensus buy rating and upside price target
- Improving forward earnings expectations
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term growth potential in ADAS and LiDAR markets
- Strategic positioning across multiple geographic regions
- Opportunity to capitalize on sector consolidation
Key Metrics & Analysis
Financial Health
Revenue Growth2.60%
Profit Margin-69.35%
P/E Ratio28.6
ROE-41.16%
ROA-10.20%
Debt/Equity123.49
P/B Ratio2.6
Op. Cash Flow$-50255000
Free Cash Flow$-1717250
Industry P/E36.8
Technical Analysis
TrendBullish
RSI46.0
Support$3.72
Resistance$5.49
MA 20$4.48
MA 50$4.02
MA 200$3.99
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price$5.84
Upside/Downside42.53%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.63
Volatility100.19%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.